NCT04507113

Brief Summary

Diffusion tensor imaging (DTI) is a non-invasive MRI technique offering a functional approach that provides morphological information about the microstructures of the nerve roots. DTI is a widely used neuroimaging technique and is a current topic of research in the field of peripheral nerve imaging.The aim of the study is to determine the prognostic quality of the DTI parameters to predict the therapeutic evolution of patients with lumbar radiculalgia at 6 months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 11, 2020

Completed
1.7 years until next milestone

Study Start

First participant enrolled

April 6, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2025

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

2.5 years

First QC Date

August 4, 2020

Last Update Submit

March 25, 2024

Conditions

Keywords

Lumbar RadiculopathyMagnetic Resonance ImagingDiffusion Tensor ImagingPrognostic

Outcome Measures

Primary Outcomes (1)

  • Predictive performance of DTI imaging on the therapeutic evolution

    DTI is a sensitive probe of cellular structure that works by measuring the diffusion of water molecules. The measured quantity is the diffusion coefficient, a proportionality constant that relates diffusive flux to a concentration gradient and has units of mm2/s. The objective is to know if the interpretation of DTI allow to predict the therapeutic evolution of patients. For instance, the patients will need in the future oral drugs? Or they will need rather an infiltration? Or they will need rather a surgery?

    6 months

Secondary Outcomes (3)

  • Correlation between DTI parameters and pain intensity

    6 months

  • Correlation between DTI parameters evolution and neuropathic pain

    6 months

  • Correlation between DTI parameters evolution and disability

    6 months

Study Arms (1)

Lumbar radiculopathy

EXPERIMENTAL

Patients with acute lumbar radiculopathy (less than 3 months of evolution)

Other: DTI sequence acquisition

Interventions

DTI sequence acquisition

Lumbar radiculopathy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 ans
  • Patient with Lumbar Radiculalgia (L4, L5 or S1)
  • Pain VAS (Visual analog scale) \> 30/100
  • Less than 3 months of evolution
  • With a radiculalgia superior or equal to lumbalgia
  • Disco radicular conflict, verified by MRI
  • Able to receive information
  • Affiliated to French social security

You may not qualify if:

  • History of chronic lumbalgia and radiculalgia
  • History of lumbar surgery
  • Recent episode (less than 6 months) with the same radicular topography
  • Bilateral radicular compression on MRI
  • Patient requiring emergency surgery
  • Evolutive disease interfering with pain assesment (neoplasia, inflammatory rheumatism, peripheral neuropathy, central neurological disease)
  • MRI contraindication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier de l'Institut Catholique de Lille

Lomme, 59 462, France

RECRUITING

MeSH Terms

Conditions

Radiculopathy

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Jean-François BUDZIK, MD, PhD

    Lille CU

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie Paule LEBITASY, MD, PhD

CONTACT

Lucile POISSON, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2020

First Posted

August 11, 2020

Study Start

April 6, 2022

Primary Completion

October 6, 2024

Study Completion

November 6, 2025

Last Updated

March 26, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations